NCT02028663View on ClinicalTrials.gov

Study to Evaluate the Safety and Efficacy of CJ-12420 in Patients With Erosive Esophagitis

PHASE2CompletedINTERVENTIONAL
Enrollment

206

Participants

Timeline

Start Date

May 31, 2013

Primary Completion Date

May 31, 2014

Study Completion Date

May 31, 2014

Conditions
Erosive EsophagitisGERD
Interventions
DRUG

CJ-12420

Once daily, Oral administration

DRUG

Esomeprazole

Once daily, Oral administration

Trial Locations (1)

Unknown

Seoul National University Hospital and 11 others, Seoul

Sponsors
All Listed Sponsors
lead

HK inno.N Corporation

INDUSTRY

NCT02028663 - Study to Evaluate the Safety and Efficacy of CJ-12420 in Patients With Erosive Esophagitis | Biotech Hunter | Biotech Hunter